Solid lipid nanoparticles (SLN) consisting of tristearin or tribehenin, and monoolein aqueous dispersions (MAD) consisting of glyceril-monoolein have been studied as potential nanocarriers for nucleic acids. The cationic character of nanocarriers was obtained by adding cationic surfactants, such as diisobutylphenoxyethyl-dimethylbenzyl ammonium chloride (DEBDA) or PEG-15 Cocopolyamine (PCPA), to the lipid composition. The products were characterized in terms of size and morphology by Cryo-TEM and PCS. The charge properties were determined by measuring the zeta potential. Our experimental protocol enabled us to obtain homogeneous and stable cationic nanosystems within 3-6 months from production. Assessment of cytotoxicity on HepG2 cells by...
Gene transfer represents an important advance in the treatment of both genetic and acquired diseases...
Solid lipid nanoparticles (SLNs) have been proposed in the 1990s as appropriate drug delivery system...
Solid lipid nanoparticles (SLNs) have been proposed in the 1990s as appropriate drug delivery system...
Gene therapy is a pharmacological regimen of great interest for the treatment of genetic, neoplastic...
The suitability of cationically modified solid-lipid nanoparticles (SLN) as a novel transfection age...
The suitability of cationically modified solid-lipid nanoparticles (SLN) as a novel transfection age...
The suitability of cationically modified solid-lipid nanoparticles (SLN) as a novel transfection age...
The purpose of this study was to investigate the potential of new positively charged solid lipid nan...
Cationic lipid- and polymer-based nanodevices are considered appropriate alternatives for virus-base...
Cationic lipid- and polymer-based nanodevices are considered appropriate alternatives for virus-base...
Cationic solid lipid nanoparticles (SLN) are promising nonviral gene delivery carriers suitable for ...
Cationic solid lipid nanoparticles (SLN) are promising nonviral gene delivery carriers suitable for ...
Solid lipid nanoparticles (SLNs) have been proposed in the 1990s as appropriate drug delivery system...
The aim of the present work was to produce a cationic solid lipid nanoparticle (SLN) as non-viral ve...
Gene transfer represents an important advance in the treatment of both genetic and acquired diseases...
Gene transfer represents an important advance in the treatment of both genetic and acquired diseases...
Solid lipid nanoparticles (SLNs) have been proposed in the 1990s as appropriate drug delivery system...
Solid lipid nanoparticles (SLNs) have been proposed in the 1990s as appropriate drug delivery system...
Gene therapy is a pharmacological regimen of great interest for the treatment of genetic, neoplastic...
The suitability of cationically modified solid-lipid nanoparticles (SLN) as a novel transfection age...
The suitability of cationically modified solid-lipid nanoparticles (SLN) as a novel transfection age...
The suitability of cationically modified solid-lipid nanoparticles (SLN) as a novel transfection age...
The purpose of this study was to investigate the potential of new positively charged solid lipid nan...
Cationic lipid- and polymer-based nanodevices are considered appropriate alternatives for virus-base...
Cationic lipid- and polymer-based nanodevices are considered appropriate alternatives for virus-base...
Cationic solid lipid nanoparticles (SLN) are promising nonviral gene delivery carriers suitable for ...
Cationic solid lipid nanoparticles (SLN) are promising nonviral gene delivery carriers suitable for ...
Solid lipid nanoparticles (SLNs) have been proposed in the 1990s as appropriate drug delivery system...
The aim of the present work was to produce a cationic solid lipid nanoparticle (SLN) as non-viral ve...
Gene transfer represents an important advance in the treatment of both genetic and acquired diseases...
Gene transfer represents an important advance in the treatment of both genetic and acquired diseases...
Solid lipid nanoparticles (SLNs) have been proposed in the 1990s as appropriate drug delivery system...
Solid lipid nanoparticles (SLNs) have been proposed in the 1990s as appropriate drug delivery system...